ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 22 of 124 for:    vitiligo

Leucotrichia in Vitiligo

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03402633
Recruitment Status : Completed
First Posted : January 18, 2018
Last Update Posted : January 18, 2018
Sponsor:
Information provided by (Responsible Party):
Maha Fathy Elmasry, Cairo University

Brief Summary:
The incidence of leucotrichia has been reported to range from 9 to 48.4% of all vitiligo patients.Leucotrichia is more often observed in segmental vitiligo with a very high percentage. However, further studies considering the prevalence of leucotrichia in different types of vitiligo need to be conducted.

Condition or disease Intervention/treatment
Leucotrichia Other: Examination of leukotrichia in vitiligo patients

Study Type : Observational
Actual Enrollment : 107 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Leucotrichia in Vitiligo Patients : A Cross Sectional Study
Actual Study Start Date : April 2016
Actual Primary Completion Date : September 2016
Actual Study Completion Date : September 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Vitiligo


Intervention Details:
  • Other: Examination of leukotrichia in vitiligo patients
    Examination of leukotrichia will be enhanced by wood's light and dermoscopy for better enhancing of the lesions and good magnification


Primary Outcome Measures :
  1. Detection of prevalence of leukotrichia within vitilignous areas in vitiligo patients [ Time Frame: within 6 months ]
    Detection of prevalence of leukotrichia within vitilignous areas in vitiligo patients



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Vitiligo patients with/ without leukotrichia within the vitiliginous areas presenting to dermatology outpatient clinic at Kasr Alainy Teaching Hospital
Criteria

Inclusion Criteria:

  • Age > 18
  • Vitiligo patients with/ without leukotrichia within the vitiliginous areas

Exclusion criteria:

  • Age < 18
  • Premature hair graying in the trunk before the age of 30

Responsible Party: Maha Fathy Elmasry, principal investigator, Cairo University
ClinicalTrials.gov Identifier: NCT03402633     History of Changes
Other Study ID Numbers: Dermatology5
First Posted: January 18, 2018    Key Record Dates
Last Update Posted: January 18, 2018
Last Verified: January 2018

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Vitiligo
Hypopigmentation
Pigmentation Disorders
Skin Diseases